This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

R1 RCM Past Earnings Performance

Past criteria checks 0/6

R1 RCM has been growing earnings at an average annual rate of 11.1%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 16.9% per year.

Key information

11.1%

Earnings growth rate

18.8%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate16.9%
Return on equity-2.2%
Net Margin-2.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment

Mar 03

Calculating The Fair Value Of R1 RCM Inc. (NASDAQ:RCM)

Oct 03
Calculating The Fair Value Of R1 RCM Inc. (NASDAQ:RCM)

Returns At R1 RCM (NASDAQ:RCM) Are On The Way Up

Sep 03
Returns At R1 RCM (NASDAQ:RCM) Are On The Way Up

Is Now An Opportune Moment To Examine R1 RCM Inc. (NASDAQ:RCM)?

Jul 18
Is Now An Opportune Moment To Examine R1 RCM Inc. (NASDAQ:RCM)?

Why We're Not Concerned About R1 RCM Inc.'s (NASDAQ:RCM) Share Price

Jul 03
Why We're Not Concerned About R1 RCM Inc.'s (NASDAQ:RCM) Share Price

R1 RCM Inc. (NASDAQ:RCM) Shares Could Be 40% Below Their Intrinsic Value Estimate

Jun 05
R1 RCM Inc. (NASDAQ:RCM) Shares Could Be 40% Below Their Intrinsic Value Estimate

R1 RCM Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 06
R1 RCM Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

R1 RCM (NASDAQ:RCM) Might Have The Makings Of A Multi-Bagger

Mar 17
R1 RCM (NASDAQ:RCM) Might Have The Makings Of A Multi-Bagger

Is R1 RCM Inc. (NASDAQ:RCM) Trading At A 42% Discount?

Jan 06
Is R1 RCM Inc. (NASDAQ:RCM) Trading At A 42% Discount?

Revenue & Expenses Breakdown

How R1 RCM makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:RCM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,464-612410
30 Jun 242,380-402330
31 Mar 242,313-332370
31 Dec 232,25432200
30 Sep 232,212-352190
30 Jun 232,135-652220
31 Mar 231,966-911900
31 Dec 221,806-631730
30 Sep 221,672-11520
30 Jun 221,556451270
31 Mar 221,518911260
31 Dec 211,475-5051220
30 Sep 211,404-4951160
30 Jun 211,332-5121080
31 Mar 211,293-5261030
31 Dec 201,270471010
30 Sep 201,256141020
30 Jun 201,250161050
31 Mar 201,23131080
31 Dec 191,186-91050
30 Sep 191,135-221060
30 Jun 191,084-421070
31 Mar 19997-411040
31 Dec 18869-64980
30 Sep 18746-99840
30 Jun 18619-88690
31 Mar 18510-92590
31 Dec 17450-76560
30 Sep 17416-28600
30 Jun 17418-3650
31 Mar 17327-36710
31 Dec 1659365740
30 Sep 1655568730
30 Jun 1644517750
31 Mar 1645835780
31 Dec 15117-84750
30 Sep 1596-107770
30 Jun 15171-65720
31 Mar 15208-55710
31 Dec 14210-80760
30 Sep 14247-56700
30 Jun 14174-103760
31 Mar 14490102750
31 Dec 13505130800

Quality Earnings: RCM is currently unprofitable.

Growing Profit Margin: RCM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RCM is unprofitable, but has reduced losses over the past 5 years at a rate of 11.1% per year.

Accelerating Growth: Unable to compare RCM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RCM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).


Return on Equity

High ROE: RCM has a negative Return on Equity (-2.18%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies